Sylvester Comprehensive Cancer Center


RAGE inhibition in mice prevents metastasis of human breast cancer cells (stained brown) to lung and other tissues.

Sylvester researchers identify receptor to slow breast cancer metastasis


In a research study published today in the journal Oncogene, scientists from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine showed that by therapeutically targeting the receptor for advanced glycation end-products (RAGE) in breast cancer cells, they decreased tumor growth, reduced tumor angiogenesis and recruitment of inflammatory cells, and dramatically decreased metastasis to the lung and the liver.

From left, Kerry Burnstein, Ph.D., with Priyamvada Rai, Ph.D.

Perfect Synergy between Sylvester Researchers Leads to $1.15 Million DOD Idea Development Award


Sylvester Comprehensive Cancer Center and University of Miami Miller School of Medicine researchers Priyamvada Rai, Ph.D., associate professor of medicine/hematology and oncology, and Kerry Burnstein, Ph.D., professor of molecular and cellular pharmacology, have received a $1.15 million Idea Development Award from the Department of Defense (DOD) to investigate a novel mechanism of inhibiting incurable prostate cancer.

Nestor Villamizar, M.D.

Sylvester Earns Lung Cancer Screening Center Designation by the American College of Radiology


The lung cancer screening program at Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System, has been designated an American College of Radiology (ACR) Lung Cancer Screening Center. The voluntary designation signifies that the program and protocol meet the requirements set forth by the ACR lung cancer screening committee.

Back row, from left, Cathy Rosenberg, Ricardo J. Komotar, M.D., Macarena de la Fuente, M.D., Suzy Selby and Allan D. Levi, M.D. Front row, from left, Nancy and Stanley Engle.

Pledge Will Provide Advocate for Brain Tumor Patients


Spurred on by first-hand experience, Stanley and Nancy Engle recently made a generous commitment to help ease the difficulties facing brain tumor patients. The couple announced a $400,000 gift for a joint initiative of the Sylvester Comprehensive Cancer Center and the Department of Neurological Surgery at the University of Miami Miller School of Medicine known as the UM Brain Tumor Initiative.

Theodore J. Lampidis, Ph.D.

Sylvester’s Dr. Theodore J. Lampidis Honored by Congress for His Cancer Research


Theodore J. Lampidis, Ph.D., a cell biology and anatomy expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, recently received recognition from the 144th Congress of the United States in honor of his work studying the combination of two non-toxic drugs as a universal treatment for cancer.

Miami Epigenetics & Cancer Symposium, November 28-29


The Miami Epigenetics & Cancer Symposium, hosted by the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, will be held at the Ritz-Carlton, Miami Beach on November 28-29. The symposium will bring together world-renowned scientists to discuss the latest discoveries in genomic and epigenetic approaches to understanding the molecular underpinning of cancer development and progression.